logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5447.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5447.produseast1
MSF Scientific Days International 2024 | Collections | MSF Science Portal
MSF Scientific Days International 2024

MSF Scientific Days International 2024

On 16 May people from within and outside MSF will gather in London, joined by online participants from over 100 countries, for this annual ‘conference without borders’ showcasing medical research from fragile and conflict affected settings.

All too often the populations MSF and others work with are excluded from the benefits of research. Yet they are the ones that often need these benefits most. So speakers will consider how MSF’s research has impacted the way our projects deliver care, how knowledge gaps can be pivotal to political gatekeeping and to triggering appropriate humanitarian responses, and how identifying best practices and funding innovation are key to improving our capacity to act.

Here you can view abstracts for all scientific presentations, which focus on infectious diseases, outbreaks, vaccination, and mortality.

Collection Content

Conference Material
|
Video

A novel personal protective equipment for filovirus outbreaks: a usability study under simulated field conditions

Dorion C
2024-05-25 • MSF Scientific Day International 2024
2024-05-25 • MSF Scientific Day International 2024

See more collections

World Hepatitis Day 2023
World Hepatitis Day 2023
Viral hepatitis is a major cause of disease and death globally. To mark World Hepatitis Day (July 28th) we present a selection of recent MSF research exploring how to effectively deploy powerful medical tools that could turn the tide on hepatitis C and E—but now reach only a tiny fraction of people who desperately need them, especially in low-resource and emergency settings. For hepatitis C, where groundbreaking new antiviral drugs can cure nearly all patients, MSF is piloting simplified, community-based models of care that offer rapid screening, diagnosis, and treatment under one roof. Some programs focus on the complex needs of highly vulnerable, hard-to-reach populations, such as people co-infected with HIV or TB or who inject drugs. Turning to prevention, an ongoing vaccination campaign against hepatitis E in an outbreak setting is showing early signs of short-term protection. Final results from this South Sudanese refugee camp, where poor sanitation and water quality regularly lead to outbreaks, should help plug a key evidence gap that—along with other barriers discussed in a commentary article—impedes widespread uptake of the vaccine.
World Refugee Day 2022
World Refugee Day 2022

As we mark World Refugee Day (20 June 2022), over 100 million people globally are forcibly displaced from their home—the highest number ever recorded, according to the United Nations Refugee Agency. The health impacts of this displacement are dire: millions of people exposed to violence, infectious disease, and exclusion from health care during often-treacherous journeys or in detention centers and refugee camps.


Here we bring you a selection of MSF research aimed at better understanding and meeting the medical needs of populations along their migration route. Some studies describe the physical and psychological wounds our teams witness among specific populations—from unaccompanied minors to people detained under inhumane conditions in Libya or rescued from drowning after risking everything in perilous Mediterranean Sea crossings. Others assess ways to improve models of care for refugees with chronic diseases like hypertension and diabetes, or for tackling infectious diseases such as diphtheria and hepatitis E in overcrowded, unhygienic camps.

TB Union Conference 2022
TB Union Conference 2022
Innovation in preventing, diagnosing and treating drug-resistant tuberculosis (DR-TB) cannot come fast enough—especially given the ground lost due to the Covid-19 pandemic, and with only 1 in 3 people who have DR-TB now receiving care. The content collection linked below offers a snapshot of recent TB work by MSF and collaborators to help change this picture. The TB-PRACTECAL and endTB studies have delivered clear evidence for shorter, safer, more effective treatments against drug-resistant (DR)-TB. Faced with the many hurdles that lie ahead before these and other critical interventions can be widely accessible, other studies investigate patient/family-based models of care adapted to complex settings and neglected groups, including children. Last, several authors explore limited but potentially important options for expanding diagnosis and preventive treatment.
View All Collections